Beijing. As population aging accelerates in China, Parkinson’s disease has emerged as an increasingly common chronic condition among older adults, prompting Xuanwu Hospital of Capital Medical University in Beijing to launch the country’s first artificial intelligence (AI)-powered digital medical consultation platform aimed at treating the disease.
Based on clinical data and medical literature, the platform is designed to reduce repetitive consultations and provide patients with easier access to reliable information.
Led by the hospital’s Parkinson’s disease research team, the AI system incorporates more than 20 years of clinical research from Xuanwu Hospital, including medical records, studies, reports and educational materials, along with peer-reviewed literature.
AI can answer up to 90 percent of patients’ routine queries, freeing doctors to focus on more complex cases, said Chen Biao, director of the hospital’s Parkinson’s Disease Treatment and Clinical Research Center.
Using their smartphones, patients can ask questions about Parkinson’s disease to the AI-powered medical consultation system and receive science-based answers. Although the system effectively handles general questions, it does not provide specific treatment advice, ensuring that clinical decision-making remains in the hands of doctors. The system also provides direct links to Xuanwu Hospital’s online platform for appointment booking and drug prescription services.
The platform is expected to be integrated with wearable devices to support medication guidance, rehabilitation training, daily care and psychological support, building a comprehensive long-term care partnership between patients and doctors, Chen added.